IL2 and ovarian carcinoma: Research findings also indicate that ovarian cancer patients with TILs exhibit increased intratumoral expression of INF-γ, IL-2, and T-cell-associated chemokines alongside having postponed disease recurrence and death while patients with no TIL have profiles of elevated levels of vascular endothelial growth factor (VEGF) expression (15).